Back
Corporacion Interamericana de Entretenimiento SAB de CV 10K Form
Buy
52
CIEZF
Corporacion Interamericana de Entretenimiento SAB de CV
Last Price:
1.2000
Seasonality Move:
399900%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CIEZF News And Ratings
See the #1 stock for the next 7 days that we like better than CIEZF
CIEZF Financial Statistics
Sales & Book Value
Annual Sales: | $276.58M |
---|---|
Cash Flow: | $8.07M |
Price / Cash Flow: | 12.23 |
Annual Sales: | $0.54 |
Price / Book: | 2.24 |
Profitability
EPS (TTM): | 0.15130 |
---|---|
Net Income (TTM): | $84.53M |
Gross Margin: | $61.01M |
Return on Equity: | 25.81% |
Return on Assets: | 10.73% |
Corporacion Interamericana de Entretenimiento SAB de CV Earnings Forecast
Key Corporacion Interamericana de Entretenimiento SAB de CV Financial Ratios
- The Gross Profit Margin over the past 22 years for CIEZF is 22.06%.
- The Selling, General & Administrative Expenses for CIEZF have been equal to 3.74% of Gross Profit Margin.
- The Interest Expense is 18.62% of Operating Income.
- The Net Earning history of CIEZF is 24.74% of Total Revenues.
- Per Share Earnings over the last 22 years have been positive in 9 years.
Corporacion Interamericana de Entretenimiento SAB de CV Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | OTCM |
---|---|
Industry: | Entertainment |
Sector: | Communication Services |
Current Symbol: | CIEZF |
Website: | cie.com.mx |
Debt
Debt-to-Equity Ratio: | 0.25 |
---|---|
Current Ratio: | 0.98 |
Quick Ratio: | 0.68 |
Price-to-Earnings
Trailing P/E Ratio: | 9.8 |
---|---|
Forward P/E Ratio: | 0 |
CIEZF Technical Analysis vs Fundamental Analysis
Buy
52
Corporacion Interamericana de Entretenimiento SAB de CV (CIEZF)
is a Buy
Is Corporacion Interamericana de Entretenimiento SAB de CV a Buy or a Sell?
-
Corporacion Interamericana de Entretenimiento SAB de CV stock is rated a Buy
The current Corporacion Interamericana de Entretenimiento SAB de CV [CIEZF] share price is $1.2000. The Score for CIEZF is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.